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1 Abstract 
Iron uptake into mitochondria is of key importance for iron-sulfur cluster biogenesis, for 
heme synthesis and for the function of many mitochondrial proteins. In S. cerevisiae, the 
mitochondrial carrier proteins Mrs3p and Mrs4p had previously been identified to be the main 
iron transporters under iron limiting conditions. However, several indications point to the 
possibility that these proteins do not represent the sole system of mitochondrial iron import. 
Interestingly, the mitochondrial pyrimidine nucleotide transporter Mrs12p had recently been 
found to function as multi-copy suppressor of the mrs3/4∆ phenotype and therefore is a 
possible candidate for low-affinity mitochondrial iron uptake.  
In this work, Mrs12p’s involvement in mitochondrial iron uptake and the role of pyridimine 
transport in the proteins’s ability to suppress the mrs3/4∆ phenotype were studied.  
FET3-expression in mrs3/4/12∆ and mrs3/4∆ mutants was monitored by GFP-expression and 
microarray data showing induction of genes belonging to the iron-regulon of a mrs3/4/12∆ 
mutant were compared to mrs12∆ gene expression. Both FET3-expression and genome wide 
expression profiling pointed to a role of Mrs12p in mitochondrial iron acquisition.  
For studying the role of pyrimidine transport, a mutant in contact site II of Mrs12p was 
created. Overexpression of the mutated gene did not complement the mrs12∆ phenotype and 
no pyrimidine transport into mitochondria carrying the mutated protein was observed. 
Suppression of the mrs3/4∆ phenotype in growth tests was not seen and iron uptake into 
submitochondrial particles (SMPs) was significantly reduced when compared to wild-type 
SMPs or mrs3/4∆ SMPs overexpressing MRS12.  
Besides suppression of the mrs3/4∆ phenotype, it had already been reported that 
overexpression of MRS12 also suppresses the mrs2∆ phenotype, which is due to lack of 
mitochondrial Mg2+ uptake. Considering this, we assumed a function of Mrs12p in not only 
iron, but low-affinity divalent metal transport and therefore looked at mitochondrial Mg2+ 
uptake in more detail. Transport studies into mitochondria using the fluorescent Mg2+-chelator 
mag-fura 2 showed that overexpression of MRS12 enhances Mg2+ transport into 
mrs2∆ mitochondria, but no increase in Mg2+ transport was seen in the case of the mutant. 
Also, overexpression of the mutated gene did not suppress the mrs2∆ phenotype. 
These observations imply that Mrs12p transports Fe2+ and Mg2+ into mitochondria together 
with pyrimidine nucleotides. The relevance of these results for divalent cation uptake into 
yeast mitochondria will be discussed in the last part of this work.  
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Zusammenfassung 
Für Mitochondrien ist die Aufnahme von Eisen für die Eisen-Schwefel Cluster Biogenese, für 
die Haem-Synthese und für die Funktion vieler mitochondrialer Proteine von entscheidender 
Bedeutung. In S. cerevisiae hatte man bereits zwei mitochondriale Carrier Proteine, Mrs3p 
und Mrs4p, identifiziert, welche für den Eisentransport unter Eisenmangelzustand 
verantwortlich sind. Einige Beobachtungen weisen jedoch darauf hin, dass diese Proteine 
nicht das einzige System zur Eisenaufnahme ausmachen. Interessanterweise ist der 
mitochondriale Pyrimidin-Nukleotid Transporter Mrs12p in der Lage, als Multi-Copy 
Suppressor des mrs3/4∆ Phenotyps zu wirken und stellt daher einen Kandidaten für 
Eisenaufnahme bei normalen Eisenkonzentrationen in der Zelle dar.  
In dieser Arbeit soll die Beteiligung von Mrs12p an der mitochondrialen Eisenaufnahme und 
die Rolle, die der Pyrimidintransport bei der Suppression des mrs3/4∆ Phenotyps spielt, 
untersucht werden.  
Die Expression von FET3 einer mrs3/4/12∆ und einer mrs3/4∆ Mutante wurde mittels GFP-
Expression beobachtet und Microarray Daten, welche die Induktion von Genen des Eisen-
Regulons einer mrs3/4/12∆ Mutante aufzeigen, wurden dargestellt und mit der Genexpression 
einer mrs12∆ Mutante verglichen. FET3-Expression und Expression Profiling weisen auf eine 
Rolle von Mrs12p beim mitochondrialen Eisen-Erwerb hin.  
Um die Rolle des Pyrimidin-Transports zu untersuchen, wurde eine Mutante im Kontaktpunkt 
II von Mrs12p hergestellt. Überexpression des mutierten Gens führte zu keiner Suppression 
der mrs12∆ Mutante und keine Pyrimidin-Aufnahme konnte in Mitochondrien, welche das 
mutierte Protein besaßen, beobachtet werden. In Wachstumstests wurde keine Suppression 
des mrs3/4∆ Phenotyps gesehen und Eisen-Aufnahme in submitochondriale Partikel (SMPs) 
war im Vergleich zu Wild-Typ SMPs oder mrs3/4∆ SMPs, die MRS12 überexprimierten, 
deutlich reduziert. 
Vor dieser Arbeit war bereits bekannt, dass Überexpression von MRS12, außer zur 
Suppression des mrs3/4∆ Phenotyps, auch zur Suppression des mrs2∆ Phenotyps führt. Dieser 
Phenotyp kommt durch das Fehlen des mitochondrialen Mg2+ Transporters Mrs2p zustande. 
Das führte uns zu der Annahme, dass Mrs12p nicht nur eine Funktion als Eisentransporter, 
sondern als Transporter mit geringer Affinität zu verschiedenen divalenten Metallen haben 
könnte. Daher untersuchten wir die mitochondriale Mg2+-Aufnahme im Detail mittels 
Transportstudien an Mitochondrien mit dem fluoreszierenden Mg2+-Chelator mag-fura 2. 
Diese zeigten, dass Überexpression von MRS12 den Mg2+ Transport fördert, bei Expression 
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der Mutante wurde jedoch keine Zunahme gesehen. Überexpression des mutierten Gens 
führte auch zu keiner Suppression des mrs2∆ Phenotyps. 
Diese Beobachtungen zeigen, dass Fe2+ und Mg2+ gemeinsam mit Pyrimidin-Nukleotiden von 
Mrs12p in die Mitochondrien transportiert werden. Abschließend wird die Bedeutung dieser 
Ergebnisse für die Aufnahme divalenter Kationen in die Mitochondrien der Hefe diskutiert.  
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2 Introduction 
2.1 The Role of Iron and its Acquisition by Living Cells 
Iron is of key importance to the biology of all eukaryotes and the vast majority of prokaryotes. 
Its ability to shift between two redox states and to gain and lose electrons easily makes it a 
perfect candidate for the metal centers of nature’s redox reaction performing enzymes. The 
metal is involved in vital biological processes like oxygen transport, oxidative 
phosphorylation, DNA biosynthesis, and xenobiotic metabolism (Hentze, Muckenthaler et al. 
2004) and it is part of such important proteins as cytochromes, oxygenases, flavoproteins, and 
redoxins. In mammalian hemoglobin, it provides a specific binding site for oxygen and 
thereby enables oxygen delivery to tissues of multicellular organisms (Andrews 2000). 
Although iron belongs to the most abundant metals on earth, it is poorly bioavailable, as it is 
generally present in the ferric (Fe3+) form, which is almost insoluble in water at neutral pH. A 
second problem of iron chemistry for organisms is that the metal’s ability to donate electrons 
can lead to the formation of free radicals; when ferrous iron (Fe2+) interacts with H2O2, it 
undergoes the Fenton reaction (Papanikolaou and Pantopoulos 2005). The Fenton reaction 
produces ferric iron, -OH, and the hydroxyl radical, whereby the latter may attack adjacent 
lipids and lead to oxidative damage of DNA and other macromolecules. For these reasons, 
complex iron-transport and management systems have evolved in virtually all organisms, 
which will be discussed in more detail below.  
2.1.1 Iron Acquisition by Living Cells 
Bacteria. In bacteria, when intracellular iron level is elevated, the protein Fur (for ferric 
uptake regulator) is expressed, whose function is to repress transcription initiation of iron-
uptake genes (Ernst, Bennett et al. 1978). When growing under iron depletion conditions, 
bacteria produce low-molecular-weight molecules called siderophores. The siderophores are 
secreted into the environment and make iron soluble before it is transported inside the cell. 
The iron-siderophore complex binds to outer-membrane receptors and is actively transported 
across the outer and the inner membrane into the cytoplasm. Here, it is assumed that the metal 
is released from the siderophore, reduced to the soluble ferrous iron (Fe2+), and sequestered 
into iron-using proteins (Masse and Arguin 2005). 
Yeast. In S. cerevisiae, there are several transport systems that transfer iron across the cell 
surface (Van Ho, Ward et al. 2002). Two non-specific or low-affinity transport systems are 
located at the plasma membrane. These proteins, which are products of the FET4 and SMF1 
genes, not only transport iron, but can also take up other transition metals. In addition to these 
low-affinity systems, there are two high- affinity transport systems, providing the cell with the 
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ability to adjust its uptake system under iron-deplete conditions. The first system involves the 
transport of siderophore-iron complexes, similar to those of bacteria, whereas the second 
transport system is comprised of two cell surface proteins, Fet3p, a multicopper oxidase, and 
Ftr1p, a transmembrane permease. Fet3p oxidizes ferrous iron to ferric iron and Ftr1p 
transports ferric iron across the plasma membrane (Kaplan, McVey Ward et al. 2006). The 
cell surface metalloreductases Fre1p and Fre2p provide the substrate for Fet3p by reducing 
Fe3+ and passing on Fe2+ to Fet3p (Georgatsou and Alexandraki 1994). Increased expression 
of iron transport genes is induced by the activity of the iron-sensing transcription factor Aft1p 
(Yamaguchi-Iwai, Dancis et al. 1995) and its paralogue Aft2p, which is able to bind to the 
promoter elements of genes that code for cell surface iron transporters (Rutherford, Jaron et 
al. 2003). When cells suffer from low iron, Aft1p relocalizes to the nucleus. There, it 
functions as an activating transcription factor for the promoters on approximately 20 genes, 
usually referred to as the iron-regulon (Yamaguchi-Iwai, Ueta et al. 2002; Shakoury-Elizeh, 
Tiedeman et al. 2004, Figure 1). Induction of these genes increases the cell’s ability for iron 
uptake and remodels intracellular metal homeostasis in response to low iron levels.  
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Figure 1: The Iron Regulon of S. cerevisiae. The iron-regulon comprises cell wall proteins involved in 
siderophore uptake (FIT1, FIT2, FIT3), metalloreductases for iron and copper uptake (FRE1, FRE2, FRE3, 
FRE4, FRE5, FRE6), transporters for ferrous iron uptake (FET3, FTR1) and siderophore uptake (ARN1, ARN2, 
ARN3, ARN4), intracellular transporters which play a role in metal homeostasis (CCC2, FTH1, SMF3, COT1) 
and proteins of biotin uptake, copper or heme metabolism or of unknown function (VHT1, ATX1, HMX1, TIS11). 
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Mammals. In mammals, iron is absorbed from the diet in the duodenal part of the intestines 
by the divalent metal transporter 1 (DMT1, also called Nramp2 and DCT1 (Gunshin, 
Mackenzie et al. 1997)). Export of iron (as Fe2+) from the barrier cells of the duodenum and 
release into the blood is mediated by ferroportin (also referred to as IREG1 and MTP1 
(McKie, Marciani et al. 2000)). Ferroportin either cooperates with hephaestin (Vulpe, Kuo et 
al. 1999) or ceruloplasmin (Harris, Durley et al. 1999), multicopper oxidases that convert Fe2+ 
into Fe3+ (ceruloplasmin is a homologue of yeast Fet3p). As iron is able to bind to many 
proteins, it is transported in the serum in the Fe3+ form by a specific carrier, transferrin 
(Ponka, Beaumont et al. 1998), which also ensures that iron stays in the non-reactive ferric 
form and does not engage in electron transfer reactions. When cells need iron, they take up 
transferrin that contains bound iron by transferrin receptors. These proteins are present on the 
cell surface in amounts depending on the cell’s demand for iron. The transferrin-transferrin 
receptor-complex is internalized by clathrin-mediated endocytosis. Endosomes are acidified 
by vesicular membrane proteins that pump protons, and iron is released from transferrin upon 
the change in pH. Apotransferrin and the transferrin-receptor are recycled back to the plasma 
membrane, where apotransferrin dissociates from the receptor upon normal pH (Hentze, 
Muckenthaler et al. 2004). The iron in the acidified endosome is transferred via DMT1 to the 
cytoplasm, where it is either used for cellular proteins and processes requiring iron or stored 
by the major iron-storage protein ferritin (Harrison and Arosio 1996) (Figure 2).  
 
 
Figure 2: Iron Distribution and Storage inside Mammalian Cells. Iron (III) from the diet is reduced by 
DCYTB (duodenal cytochrome b-like ferrireductase) and iron (II) enters absorptive cells of the intestinal 
epithelium or storage cells through DMT1 (divalent metal transporter 1). Export of iron (III) is mediated by 
ferroportin (FPN) after oxidation of iron (II) by hephaestin (HEPH) or ceruloplasmin (CP). In the serum, iron 
(III) is transported by transferrin (TF) and the TF-iron (III) complex is taken up by transferrin receptors into 
endosomes of cells needing iron. The iron in the endosome is transferred via DMT1 to the cytoplasma, where it 
is used for proteins or stored by ferritin (Andrews 2002). 
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Regulation of iron acquisition by the cell is mediated via several pathways. The mRNA of the 
transferrin receptor, for example, contains iron-regulatory elements (IREs) (Casey, Hentze et 
al. 1988), which are recognized by iron-regulatory proteins (IRPs) (Hentze and Kuhn 1996). 
IRPs are activated under iron-deplete conditions and promote translation of transferrin 
receptor mRNA. The transferrin receptor is further regulated at the transcriptional level by 
dimerized hypoxia inducible factor (HIF-1α and HIF-1β) (Lok and Ponka 1999), which 
enhance promoter activity, and at protein level by the hereditary hemochromatosis protein 
(HFE), which binds to the transferrin receptor in competition with transferrin and so blocks 
transferrin binding (Lebron, West et al. 1999). A negative regulator of plasma iron is 
hepcidin, a peptide hormone which inhibits iron efflux by binding ferroportin and leading to 
the degradation of the iron exporter (Nemeth, Tuttle et al. 2004). Thus, regulation of iron 
metabolism in mammals occurs mainly by controlling the rate of iron absorption by the body, 
as there is no known mechanism for up-regulation of iron excretion. 
2.2 Iron Linked Disorders 
A reason to gain more insight into the molecular mechanisms of iron metabolism is that there 
are several iron linked disorders which affect humans. Two main types of disorders can be 
distinguished: iron-overload and iron-deficiency disorders. The latter consist of genetic and 
acquired anaemias. In hereditary anemias, specific transporters or auxiliary proteins which are 
involved in iron acquisition are absent or show reduced function and thereby lead to reduced 
iron levels in the body. Acquired anaemias are usually the result of inflammatory reactions 
mediated by the immune system to fight bacterial infections, as limited access to iron slows 
down bacterial growth (Schaible and Kaufmann 2004). In iron-overload disease, the binding 
capacity of transferrin is exceeded by plasma iron levels. The body is not able to 
downregulate iron absorption in response to increased iron stores and the elevated iron levels 
cause tissue damage and fibrosis. Primary iron-overload disease or hereditary 
haemochromatosis (HH) is the result of a genetic misregulation of iron acquisition. So far, 
HH has been linked to defects in four genes, three of these defective genes are involved in 
inadequate hepcidin production and the forth is caused by mutations in the iron exporter 
ferroportin (De Domenico, McVey Ward et al. 2008).  
As iron transport and iron homeostasis in mitochondria will be addressed in this work, it is 
also of interest to mention the disease Friedreich ataxia, a cardiac and neurodegenerative 
disorder. Here, iron accumulation in mitochondria is seen in the heart and central nervous 
system of affected patients due to decreased levels of the frataxin transcript. The frataxin 
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protein is proposed to participate in Fe-S cluster biogenesis (Pandolfo 2008), but the exact 
mechanism of its function is still unclear. 
2.3 Iron Homeostasis in Mitochondria 
Before addressing iron transport into mitochondria, I’d like to give a general overview on 
mitochondria and iron homeostasis. Mitochondria form an essential part of the cell volume of 
eukaryotic cells and have been crucial for the evolution of complex animals. The most 
significant role of the organelle is the generation of ATP through oxidation of pyruvate by O2 
to CO2 and H2O, which leads to a 15 times increased ATP production than that by glycolysis 
alone. Also, other key metabolic processes like fatty acid oxidation or iron-sulfur cluster 
biogenesis are localized inside the mitochondrial matrix. The mitochondrion is enclosed by a 
double membrane; the volume between the outer and the inner membrane is called the 
intermembrane space. The outer membrane is permeable to all molecules of 5000 daltons or 
less, whereas the highly convoluted inner membrane contains specific transport proteins for 
selective substrate uptake and is impermeable to ions (Alberts, Johnson et al. 2007).  
However, ions, especially iron, play an important part in the function of many mitochondrial 
proteins or metabolites. Iron is required for the generation of hemoproteins, for iron-sulfur 
cluster (Fe-S) containing proteins of the matrix (e.g. aconitase, biotin synthase, 
homoaconitase and ferredoxin) and the inner membrane and as cofactor in a class of enzymes 
which contain oxo-bridged binuclear iron centers (Pierrel, Cobine et al. 2007). Recent studies 
in S. cerevisiae show that mitochondrial iron homeostasis is regulated by components of the 
Fe-S cluster biogenesis system, as yeast strains that were depleted of Fe-S cluster scaffold 
proteins, chaperone proteins or ferredoxin involved in Fe-S cluster assembly accumulated iron 
in their mitochondria (Knight, Sepuri et al. 1998; Li, Kogan et al. 1999; Schilke, Voisine et al. 
1999) and thereby demonstrating that Fe-S clusters are crucial for maintaining mitochondrial 
iron homeostasis. Mutations in these proteins lead to activation of the iron-sensing 
transcription factor Aft1p in S. cerevisiae (described above) and increased cellular iron-uptake 
(Li, Kogan et al. 1999).  
2.3.1 The Mitochondrial Carrier Proteins Mrs3/4p and Iron Transport 
Regarding the important role of iron in mitochondrial metabolism and Fe-S cluster biogenesis, 
the question of its import into mitochondria has been of keen interest. The first mechanistic 
studies of iron import into yeast mitochondria showed that iron uptake is driven energetically 
by a membrane potential across the inner membrane, but does not require ATP (Lange, Kispal 
et al. 1999). In S. cerevisiae, the two inner membrane proteins Mrs3/4p could be linked to 
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mitochondrial iron acquisition (Muhlenhoff, Stadler et al. 2003). MRS3 and MRS4 genes had 
initially been identified in a screen for multicopy suppressors of a mitochondrial RNA 
splicing defect (Wiesenberger, Link et al. 1991) and suppressed the phenotype caused by the 
absence of the mitochondrial Mg2+ transporter Mrs2p (Waldherr, Ragnini et al. 1993). The 
two proteins show high sequence similarity and belong to the mitochondrial carrier family, a 
family of carriers found in the inner mitochondrial membrane of eukaryotes. Proteins of this 
family contain six membrane-spanning segments and have a tripartite structure. Their 
substrates vary from protons transported by the uncoupling protein up to large molecules such 
as ATP and ADP exchanged by the ADP/ATP carrier (Palmieri, Agrimi et al. 2006). A hint 
towards MRS4 function came from genome-wide transcription profiling of an AFT2-1up 
mutant, indicating that the gene is co-induced with several iron uptake genes and suggesting a 
role of this carrier in mitochondrial metal transport (Rutherford, Jaron et al. 2001). Further 
experiments showed that deletion of MRS3/4 in a frataxin deletion mutant (∆yfh1 cells) is able 
to suppress mitochondrial iron accumulation, that overexpression of MRS4 in ∆yfh1 cells 
leads to higher mitochondrial iron content and that overexpression of MRS4 in wild-type cells 
results in increased heme formation (Foury and Roganti 2002). Cells deleted in MRS3/4 show 
increased vacuolar iron transport and decreased cytosolic iron, demonstrating that expression 
levels of mitochondrial proteins can not only alter mitochondrial, but also cellular and 
vacuolar iron homeostasis (Li and Kaplan 2004). In the publication of Mühlenhoff et al., 
genome-wide expression profiling of strains deleted in MRS3/4 lead to up-regulation of 
several genes of the “iron regulon”, indicating that the two proteins participate in cellular iron 
metabolism. Biochemical studies in vivo, in organello and in vitro revealed that altered heme 
formation activities in mrs3/4∆ cells and cells overexpressing MRS3/4 were caused by 
alterations of mitochondrial iron uptake. However, this observation only became evident 
under iron-deplete conditions, as no influence of MRS3/4 expression levels on iron utilization 
in mitochondria isolated from cells grown in iron-replete medium could be detected. In iron-
replete medium, enough iron was able to enter the mitochondrion, even in absence of 
Mrs3/4p. Recent transport studies using submitochondrial particles (SMPs) showed that iron 
does not enter mrs3/4∆ SMPs, whereas it is readily taken up into SMPs prepared from wild-
type cells (Froschauer, unpublished results). 
The observations by Mühlenhoff et al. imply that there are other ways for iron to be 
transported into the mitochondria, provided that the iron concentration in the cytosol is 
sufficient. To discover novel proteins involved in yeast mitochondrial iron import, our group 
performed a multi-copy suppressor screen. In this screen, a mrs3/4∆ strain was transformed 
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with a wild-type yeast genomic library and transformants were screened on media containing 
low iron concentrations to detect genes which were able to suppress the mrs3/4∆ growth 
defect on low iron. The gene which was found with maximum frequency under the conditions 
of the screen was MRS12/RIM2 (Wiesenberger, Binder, unpublished data). 
2.3.2 The Mitochondrial Pyrimidine Carrier Mrs12p/Rim2p 
MRS12/RIM2 has originally been identified as a multicopy suppressor of the 
mrs2∆ phenotype, which results from absence of the main mitochondrial Mg2+ transporter 
Mrs2p (Van Dyck, Jank et al. 1995). It is, like MRS3/4, a member of the mitochondrial carrier 
family and has been shown to transport (deoxy)pyrimidine nucleoside triphosphates into 
mitochondria in exchange for (deoxy)pyrimidine nucleoside monophosphates (Marobbio, Di 
Noia et al. 2006). Cells deficient in MRS12/RIM2 lose their mitochondrial DNA and show, 
compared to wild-type ρ0 cells, a slow-growth phenotype on media containing glucose (Van 
Dyck, Jank et al. 1995).  
2. 4 The Topic of this Work 
To date, there was no known connection between mitochondrial iron uptake and 
Mrs12p/Rim2p function. However, in our search for a low-affinity mitochondrial iron 
transporter mediating uptake under iron replete-conditions we identified MRS12/RIM2 
(further referred to as MRS12) as multi-copy suppressor of the high-affinity iron transporters 
MRS3/4. This finding prompted us to take a closer look on Mrs12p/Rim2p (further referred to 
as Mrs12p) function and to characterize it in relation to mitochondrial iron homeostasis.  
Therefore, the first task of this work consisted in examining if there was a relation between 
MRS12 expression and cellular iron homeostasis. In order to investigate this, a FET3-GFP 
assay and subsequent genome wide expression profiling were performed. To test the 
involvement of pyrimidine transport in iron import mediated by Mrs12p, a mutant defective in 
pyrimidine transport was created and analysed in suppression studies and SMP experiments. 
The second task was to see if Mrs12p is also able to mediate mitochondrial Mg2+ uptake, as 
suppression of the mrs2∆ phenotype by MRS12 had been described before. Here, the mutant 
was compared to wild-type Mrs12p in mitochondrial Mg2+ uptake studies using the Mg2+ 
chelator mag-fura 2 and in growth tests. 
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3 Materials and Methods 
3.1 Yeast Strains and Media 
All yeast strains used in this work are listed in the following table.  
 
 
Table 1: Yeast Strains.  
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The composition of media and buffers was as follows: 
 
 
 
Table 2: Media and Buffer Composition. 
3.2 Gene Expression Profiling 
3.2.1 Growing of Cells 
Wild-type (W303 ρ0) and isogenic mutant strain (mrs3∆, mrs4∆, mrs12∆) were grown 
overnight in SD complete medium to an OD600 of about 1, diluted to an OD600 of 0.3 in SD 
complete, grown to an OD600 of 1.5 and harvested. Cell pellets were washed, frozen in liquid 
nitrogen and stored at -80°C.  
3.2.2 RNA Isolation 
The pellet was resuspended in TES solution, equal amounts of acid phenol were added, the 
solution was vortexed and incubated 45 minutes at 65°C with vortexing every 10 minutes. 
The pellet was placed on ice for 5 minutes, microcentrifuged at 15 000 rpm for 5 minutes at 
4°C. This extraction step was repeated once. Then, the aqueous top phase was transferred to a 
new tube, chloroform was added, the tube was vortexed and then centrifuged at 15 000 rpm 
for 5 minutes, 4°C. Again, the aqueous phase was transferred to a new tube, 1/10 of solution 
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volume of 3M sodium acetate, pH 5.3, and 2.5 times solution volume of ice-cold 100% 
ethanol were added and the solution was put at -80°C for one hour. Then, the tube was 
centrifuged for 10 minutes, 15 000 rpm, 4°C and 1 ml of ice-cold 70% ethanol was added. 
The tube was centrifuged for 5 minutes at 15 000 rpm, 4°C and the supernatant was taken off, 
this step was repeated. The tube was left open at RT for 5 minutes, then the pellet was solved 
in 35-40 µl of DEPC-H2O and the solution was put at 65°C for 10 minutes. 1 µl of the well 
solved RNA was pipetted to 750 µl of water, the concentration was determined by measuring 
OD260 (εRNA = 40 L·mol-1·cm-1). 
3.1.3 cDNA Generation 
30 µg of total RNA were dissolved in RNAse free water, anchored oligo-dT primer (5’-TTT 
TTT TTT TTT TTT TTT TTV N-3’, MedProbe) was added and the solution was incubated at 
65°C for 10 minutes. For each of the two labeling reactions, a reaction mix containing 5×first 
strand buffer (Invitrogen), 0.1M DTT (Invitrogen), dNTP (dATP, dCTP and dGTP 20 mM, 
dTTP 8 mM, Amersham), Cy3-dUTP or Cy5-dUTP (Amersham) and Superscript II (200 
U/µl, Invitrogen) were made and the annealed primer and RNA were added to the mixture. 
The solution was incubated at 42°C for 25 minutes, then 1 µl of enzyme was added as 
reaction booster and the mixture was incubated for another 35 minutes at 42°C. To stop the 
RT-reaction, 0.1M NaOH/2 mM EDTA was added and the solution was incubated at 65°C for 
another 15 minutes. Equal amounts of 0.1M HCl were added to neutralize the solution and 
cDNA purification was carried out using the CyScribe GFX Purification Kit (GE Healthcare). 
Wild-type Cy3 and mutant Cy5 elution solutions or verse visa were combined. Then, the 
sample volume was reduced to 5 µl or less by the use of a Speed-Vac (Hetovac, VR-1). 
3.1.4 Hybridization, Washing and Scanning 
To each 100 µl of DIG Easy Hyb solution (Roche) 10 µl of ssDNA (10 mg/ml) were added 
and the mixture was incubated at 65°C for two minutes. 80 µl of the prepared hybridization 
solution were added to the pooled pair of Cy5 and Cy3-labelled cDNA and incubated at 65°C 
for two minutes. The mixture was carefully pipetted onto the microarrays carrying coverslips, 
the microarrays were placed into a hybridization chamber partly filled with DIG Easy Hyb 
solution, the chamber was wrapped with plastic wrap and put into a box lined with wet towel 
papers. The box was placed at 37°C overnight for hybridization. The next day, the coverslip 
was removed by dipping the array in 1×SSC and the arrays were washed three times for 15 
minutes at 50°C in 50 ml Greiner tubes containing pre-warmed 1×SSC/0.1% SDS. The slides 
were rinsed twice at RT 1× SSC and then in 0.1×SSC and dried by centrifugation at 500 rpm 
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for 5 minutes. Arrays were stored in the dark, scanned with GenePix Pro 4.1 and further 
analyzed using the program limma (Linear Models for Microarray Data). 
3.2 FET3-GFP Assay 
Yeast strain W303 ρ0 and isogenic mutant strains (mrs3/4∆, mrs12∆,  mrs3/4/12∆) were 
transformed with a plasmid containing the FET3-GFP fusion protein with -trp as marker. 
Colonies emerging on –trp plate were picked and grown on patches on –trp plates overnight. 
Cells were checked for fluorescence under the fluorescence microscope (Zeiss, Axioplan 2). 
Cells containing the FET3-GFP fusion protein were grown in –trp medium with ferric 
ammonium citrate (0.5 g/10 ml stock, diluted 1:1000) overnight, diluted to an OD600 of 0.15 
in –trp medium containing ferric ammonium citrate and grown to an OD600 of 0.5. Cells 
without plasmid were used as controls. The cells were harvested by centrifugation (3 ml 
OD600 of 1, 4500 rpm, 4 min) and resuspended in 3 ml of water. The fluorescence was 
determined using the Perkin Elmer LS55 spectrofluorometer (FFA). The excitation 
wavelength was set at 480 nm and the emission wavelength was recorded from 505 to 550 
nm. GFP emission maximum was measured at 510 nm.  All measurements were performed at 
25°C in 3 ml cuvetts containing 2 ml solution under stirring conditions.  
3.3 Construction of mrs12 G245Y S246A by In Vitro Mutagenesis 
3.3.1 Primer Construction 
The gene sequence of MRS12 was obtained from the Saccharomyces Genome Database 
(http://www.yeastgenome.org) and contact point II which was to be changed was identified. 
To mutate the amino acids glycine (gene sequence GGT) and serine (gene sequence TCT) at 
contact point II into tyrosine (gene sequence TAT) and alanine (gene sequence GCT), two 
primers containing these sequences were constructed. For easy identification of the desired 
mutation, an EcoRI restriction site was introduced close to the mutation by changing the AccI 
restriction site GTATAC to GAATTC (EcoRI restriction site). 
 
mrs12mGSfw : 
5’-TTGAGTGCCTCTTATTTGTATGCTGTTGAAGGAATTCTTCAATGGCTATTATATG-3’ 
mrs12mGSrv : 
5’-ATATAATAGCCATTGAAGAATTCCTTCAACAGCATACAAATAAGAGGCACTCAAC-3’ 
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Outside primers were placed in the polylinker region of the template plasmid.  
 
pCM189fw : 
5’-AAATTACCGGATCAATTCG-3’ 
pCM189rv : 
5’-CATAACTAATTACATGATGC-3’ 
 
The template plasmid contained the MRS12 gene with an HA-tag (pAS14 in pCM189 
background, see Appendix for plasmid maps). Plasmid maps were constructed using the 
program Clone Manager (Version 4.0). 
3.3.2 PCR and DNA Gel Extraction 
The two PCR mixes consisted of buffer DyNAzyme, MgCl2 (final concentration 2.5 mM), 
dNTPs (0.2 mM), DyNAzyme-polymerase (proofreading, 1U/µl, Finnzymes), 0.5 µl plasmid 
DNA (pAS14 1 :10 dilution) as template and of primers pCM189fw and mrs12mGSrv (1 µM) 
or primers pCM189rv and mrs12mGSfw (1 µM) (50 µl total). The PCR was run for 30 cycles 
with an annealing temperature of 47°C and an extension time of 45 seconds. The PCR 
products were loaded onto a preparative gel (0.8% agarose, TAE buffer) and the bands were 
cut under UV light. The DNA was extracted from the gel with QIAquick gel extraction kit 
(Qiagen) according to protocol and eluted in elution buffer. The eluted PCR products were 
used as templates for the second PCR. This PCR was contained the same reagents like the 
first PCR, but here primer pCM189fw (1 µM), primer pCM189rv, 2.5 µl PCR product 1 and 
2.5 µl PCR product 2 as templates were used (50 µl total). The PCR was run for 35 cycles 
with an annealing temperature of 47°C. 
3.3.3 Restriction Digestion, Ligation and E.coli Transformation 
To obtain the insert for cloning, the PCR product (containing mrs12 G245Y, S246A) was cut 
with restriction enzyme BamHI (eight preparations were set up to increase the yield). The 
restriction digestions were pooled, loaded onto a preparative gel (0.8% agarose, TAE) and the 
DNA band at 1200 bp was cut under UV. The DNA was extracted with QIAquick gel 
extraction kit according to protocol and eluted in elution buffer. 
The vector for insertion (here pAS14) was also cut with BamHI, 15 minutes before the end of 
the restriction digestion 1 µl of phosphatase was added for dephosphorylation of vector ends. 
The solution was heated at 75°C for 15 min to denature the phosphatase, loaded onto a 
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preparative gel, the band at 8300 bp was cut under UV light and the DNA was purified with 
QIAquick gel extraction kit as described above. 
For the ligation, 50 ng of the cut and dephosphorylated vector, 20 ng of the cut insert, 1 µl of 
T4-ligase (Fermentas) and 1 µl 10×ligase buffer were filled up with sterile water to 10 µl and 
incubated at 16°C overnight. Controls without insert (religated vector) and without ligase 
(uncut vector) were also set up. 
Competent E.colis DH10B (CaCl2 Method, (Hanahan 1983)) were transformed with 5 µl of 
the ligation mix and plated onto LB Amp. For analysis, grown colonies were each inoculated 
into LB Amp medium and grown overnight. 
3.3.4 Miniprep, Restricton Digestion and Sequencing 
To obtain the plasmids, a miniprep was performed (Invisorb Miniprep kit, according to 
protocol). To check if the plasmid contained the desired mrs12 G245Y S246A mutation, the 
DNA was cut with EcoRI. The plasmids containing the mutation were sent for sequencing and 
the sequences were checked by a BLAST search and with the programmes Chromas (Version 
2.13) and Clustal (http://www.clustal.org). The plasmid with the mrs12 G245Y S246A 
mutation in contact point II of MRS12 and a C-terminal HA-tag was named pMH1.  
3.3.5 Subcloning 
To obtain the MRS12 gene without the HA-tag, plasmid pMH1 was cut with NotI to get rid of 
the HA-tag. The isolation of the cut plasmid by gel extraction, the religation, the 
transformation and the identification by mini prep and restriction digestion (here with BamHI 
and PstI) were performed as described above.  The resulting plasmid containing the mrs12 
G245Y S246A gene was called pMH2. 
In a further step, the MRS12 gene from plasmid pAS12 (MRS12 in pCM189 backbone), the 
mrs12 G245Y S246A gene from plasmid pMH2 and the mrs12 G245Y, S246A gene with the 
HA-tag from plasmid pMH1 were cloned into the single-copy plasmid pOLU2, which 
contains the MRS12 gene under its endogenous promoter (YCplac33 backbone). pOLU2 was 
cut with HindIII, phosphatase was added to dephosphorylate the vector, the DNA was loaded 
onto a preparative gel and the 6720 bp fragment (containing the backbone and the endogenous 
promotor) was isolated. pMH1, pMH2 and pAS12 were also cut with HindIII and added onto 
a gel. The DNA fragments containing the mrs12 G245Y S246A part  were isolated, the 
fragments were ligated to the vector backbone and the ligation transformed into competent 
E.coli as described above. Restriction digestions of the minipreps of the transformed E.coli 
cultures were performed with PstI and BamHI (vectors with desired pAS12 or pMH2 
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fragments) or BamHI only (vector with pMH1 fragment) to check the correct insertion and 
orientation of the fragments. The resulting plasmid with the wild-type MRS12 gene from 
pAS12 was called pMH3, the plasmid with mrs12 G245Y S246A -HA from pMH1 was called 
pMH4 and with mrs12 G245Y S246A from pMH2 pMH5 (all YCplac33 backbone). 
3.4 Tetrad Dissection 
3.4.1 Yeast Transformation 
The diploid strain YAS1 (W303-1A background, MRS12/mrs12∆) was inoculated into 
2×YPAD and grown overnight at 28°C. The cell titer was determined by measuring OD600. 
The culture was diluted to an OD600 of 0.5 and incubated at 28°C for 3-4 hours to an OD600 of 
about 2 (two divisions). The cells were harvested by centrifugation (4500 rpm, 4 minutes) and 
washed in sterile water. The supernatant was removed and the cells were resuspended in the 
appropriate amount of 100 mM LiAc (ml 100 mM LiAc = portions = 0.1×OD600×culture-
volume). Portions of 1 ml were transferred to eppendorf tubes and the suspension was 
incubated at 30°C for 10 minutes. A microcentrifuge tube of carrier DNA (2 mg/ml) was 
prepared by denaturing in a boiling water bath for 10 minutes and chilling immediately on ice. 
The cell suspension was centrifuged at 7000 rpm for 1 minute and the supernatant was 
removed. The transformation mix containing 240 µl PEG (50% w/v), 36 µl 1M LiAc, 52 µl 
carrier DNA and 32 µl water with plasmid DNA (2-3 µl plasmid DNA was used) per sample 
was added to each pellet and the cells were resuspended by pipetting. The suspension was 
incubated at 30°C for 30 minutes, heat shocked at 42°C for 20 minutes and centrifuged at 
7000 rpm for 1 minute. The transformation mix was removed, 150 µl of sterile water were 
pipetted onto the pellet and the suspension incubated for 5 minutes at RT. The cells were 
resuspended by pipetting or vortexing vigorously and then the cell solution was pipetted onto 
SD drop-out plates. The plates were incubated at 28°C for 2-4 days. 
3.4.2 Sporulation, Tetrad Dissection and Analysis 
Single colonies of the diploid strain YAS1 with the plasmids for complementation (here 
pMH3 and pMH5) and for the control (here YCpLac33) were streaked out on YPD plates as 
patches and grown overnight. The patches were transferred to sporulation plates and 
incubated 5 days at RT. 50 µl zymolyase-20TT (1.5 mg/ml in 1M sorbitol) was added to a 
small amount of cells (1.5 mg/ml in 1M sorbitol), vortexed and incubated 20 minutes at RT. 
500 µl of sterile water were added and the solution was streaked out on a YPD plate. Spores 
were dissected by the use of a micromanipulator (Singer Instruments). Colonies were grown 
for two to three days and then analysed by replica-plating on YPD, the drop-out plate, G418 
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(geneticin, 200 µg/ml) and on SD w/o plates containing a lawn of either JJ1A (mating type a) 
or JJ1c (mating type α) cells.  
3.5 Serial Dilutions 
3.5.1 Serial Dilutions 
The transformed strains to be tested for suppression were inoculated in 4 ml drop-out medium 
and grown overnight. Cultures were diluted to an OD of 1 and transferred to the first column 
of a microtiter plate and further diluted (first column: pure culture OD 1, then 1:10, 1:100 and 
1:1000 dilutions). Cultures were transferred onto plates for analysing the phenotype. After 
transferring the solutions to all plates (YPD, YPG, Cadmium-plates, plates with low iron 
concentration), they were incubated at 28°C or 37°C for two to four days and then scanned. 
3.6 Isolation of Yeast Mitochondria (Mitoprep) 
Precultures were grown overnight in 5 ml YPD, then transferred to 200 ml and then to 1 l 
fresh YPD or in 5 ml and 200 ml SD medium and afterwards in 1 l YPD. Cells were harvested 
at 3500 rpm (Sorvall Instruments, GSA rotor, 5 minutes, RT) and resuspended in buffer I. The 
cells were grown at 37°C on the shaker for 15 minutes, centrifuged (3500 rpm, GSA, 5 
minutes, RT) and the pellet resuspended in buffer II. After centrifugation, the pellet was 
weighed and resuspended in buffer II. 2 mg of zymolyase (in buffer II) per gram cells were 
added to the cell suspension and the suspension was incubated for 45 minutes at 28°C on the 
shaker. From now on, cells were kept on ice and the centrifuge and buffers were cooled. The 
cells were centrifuged (3500 rpm, 5 minutes, 4°C) and washed in buffer 2, centrifuged again 
and resuspended in buffer III. Then, the suspension was transferred to a Dounce homogenizer 
and homogenized with 20 strokes. The homogenized solution was centrifuged (3500 rpm, 5 
minutes, 4°C) and the supernatant was transferred to a SS-34 tube and centrifuged. The 
supernatant transferred to a SS-34 tube again and centrifuged at 10 000 rpm for 10 minutes at 
4°C to pellet mitochondria. The pellet was resuspended in 1 ml buffer III and protein 
concentration was measured at 280 nm. Aliquots of 10 mg/ml were stored at -80°C. 
3.7 Pyrimidine Uptake of Isolated Mitochondria 
To 100 µl of isolated mitochondria (10 mg/ml, solved in buffer III) 5 µl of H3-TTP (15 
Ci/mmol, Perkin Elmer) were added and the solution was incubated at 28°C for 10 minutes. 
Then, the solution was pipetted onto a glass fibre filter (Whatmann, 55 mm diameter, GFC) 
presoaked with buffer III while vacuum was applied. The filter was washed with 25 ml of 
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buffer III and placed into scintillation vial. 8 ml of LSC cocktail (Perkin Elmer Filter Count) 
were added and the emitted signal of the sample was measured by a scintillation counter.  
3.8 Fe2+-Uptake into Submitochondrial Particles (SMPs) 
3.8.1 Preparation and Loading of SMPs 
1 ml of mitochondria (10 mg/ml) were diluted 5-fold with 10 mM Tris pH 7.4, incubated on 
ice for 20 minutes and centrifuged at 27 000 rpm (for 10 minutes, 4°C, TLA 100.4). The 
pellet was resuspended in 1 ml of 250 mM sucrose, 10 mM Tris·HCl pH 7.4. The solution 
was sonicated three times for one minute at maximum intensity in an ice-bath and then 
centrifuged for 10 minutes at 10 000 rpm, 4°C. The supernatant was transferred to a new tube 
and centrifuged at 60 000 rpm for one hour, 4°C. The pellet was resuspended in 1 ml of 250 
mM sucrose buffer, 10 mM Tris pH 7.4. For loading, 5 µl (50 µM) PhenGreen SK were added 
to the SMPs, they were sonicated three times for one minute and centrifuged for 10 minutes at 
60 000 rpm, 4°C. The pellet was washed with 1 ml sucrose buffer, the centrifugation was 
repeated and the pellet was resuspended in 1 ml sucrose buffer.  
3.8.2 Measuring the Fluorescence 
The fluorescence was measured using the Perkin Elmer LS55 spectrofluorometer (FFA). 
Excitation and emission for PhenGreen SK were 506 and 520 nm. For measuring, 100 µl of 
loaded SMPs were diluted in 1.9 ml of sucrose buffer. 5 µM of an iron (II) solution and equal 
amounts of nucleotides were added to determine uptake. 
3.9 Mg2+-Uptake by Mag-Fura Measurements 
3.9.1 Loading of Mitochondria and Measuring 
Mitochondria (10 mg) were resuspended in 1 ml of buffer III containing ATP, pyruvic acid 
and succinic acid (100 ml buffer III, 0.2 g succinic acid, 0.01 g pyruvic acid, 0.03 g ATP). 30 
µl of the acetoxymethyl (AM) ester form of mag-fura 2 (50 µg mag-fura 2-AM dissolved in 
134.8 µl DMSO, purchased from Molecular Probes Inc.) and 5 µl Pluronic F-127 (100 µg 
pluronic dissolved in 250 µl DMSO, purchased from Molecular Probes Inc.) were added to 
the solution and incubated at 25°C shaking for 40 minutes to load the mitochondria with the 
dye. Then, the solution was centrifuged for two minutes at 10 000 rpm in a tabletop 
centrifuge, the supernatant was discarded and the mitochondria were resuspended in 1 ml 
buffer III containing ATP again. The solution was incubated another 40 minutes to allow the 
complete hydrolysis of the dye. After that, the samples were washed twice before measuring. 
For measuring ion concentrations, the spectroflourometer LS-55 (Perkin Elmer) with the fast 
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filter accessory (FFA), which allows fluorescence to be measured at 20 ms intervals with the 
excitation wavelength for mag-fura 2 at 340 and 380 nm and the emission wavelength at 509 
nm, was used. All measurements were performed at 25°C in 3 ml cuvettets containing 2 ml 
solution (1 mg protein/ml) under stirring conditions. To analyze [Mg2+]ext-dependent changes 
in [Mg2+]int, external [Mg2+] is increased gradually to final concentrations of 1, 5 and 10 mM. 
Continuous recordings of fluorescent intensities at 340 nm and 380 nm were transformed into 
340/380 wavelength ratios by using the computer program FL WinLab version 3.0 or 4.0. 
(Perkin Elmer) and [Mg2+]int values were calculated from the 340/380-nm ratio according to 
the formula of Grynkiewicz et al. (1985) with a dissociation constant of the mag-fura 2/Mg2+ 
complex of 1.52 in buffer III. The minimum (Rmin) and maximum (Rmax) ratios were 
determined at the end of each experiment. Rmax for mag-fura 2 was obtained by the addition of 
10% SDS to lyse the cells. Rmin was detected by the addition of 50 mM EDTA, pH 8, to 
remove all Mg2+ from the solution. 
3.10 Protein Immunodetection 
3.10.1 Growing and Harvesting of Cells and Mitochondria 
Cells were grown in SD and YPD medium and mitochondria were prepared as described in 
3.6. 
3.10.2 Determination of Protein Concentration by Lowry 
Protein concentration was determined with BIO-RAD DC kit (Lowry assay). Six standards of 
0.2-1.2 mg/ml BSA in 1% SDS were prepared (total volume 50 µl). Working reagent A´ was 
prepared (20 µl reagent S/ml reagent A). The reactions were set up in Eppendorf tubes: to 25 
µl of diluted sample (with 1% SDS) or reference 125 µl A´ were added and the solution was 
vortexed, then 1000 µl of reagent B were added and the solution was vortexed again. The 
reaction was transferred to fresh cuvettes and after 15 minutes the absorbance was read at 750 
nm in the spectrophotometer (Hitachi U-2000). 
3.10.3 SDS-PAGE 
40 µg of protein were loaded onto a 10% bisacrylamide/acrylamide gel. The resolving gel and 
stacking gel were prepared according to Sambrook/Fritsch/Maniatis (Molecular Cloning. A 
Laboratory Manual, 2nd edition, 1989). The samples for loading were prepared in Eppendorf 
tubes, consisting of 40 µg of protein and filled up with 5% SDS to 10 µl, and 3 µl of 
4×loading dye were added. The samples were heated for 5 minutes at 95°C and briefly 
centrifuged. The electrophoresis apparatus was filled with running buffer and the gel was 
loaded with the samples and marker (prestained PAGE RULER protein ladder, Fermentas). 
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Two gels were run at one time (20 mA/gel, 300V). Gels for Coomassie staining were 
incubated in staining solution and destained. After destaining, gels were washed in a 1% 
glycerine solution for 10 minutes and dried between transparent films. 
3.10.4 Western Blot and Immunodetection 
The sandwich for semi-dry blotting consisted of three layers of Whatmann paper soaked in 
transfer buffer, the nitrocellulose membrane soaked in transfer buffer, the gel and another 
three layers of Whatmann paper soaked in transfer buffer. The blot was run with 
60mA/sandwich (15V) for 45 minutes (Bio Rad, Trans Blot® Semidry Transfer Cell). 
The nitrocellulose membrane was incubated in blocking buffer (5% milk powder in TBS-T) 
overnight at 4°C. The membrane was washed three times for 10 minutes in TBS-T buffer at 
RT and incubated in anti-Rim2 antibody (1:5000, 2.5% milk powder in TBS-T, kindly 
provided by Prof. Fernando Palmieri, University of Bari, Department of Pharmaco-Biology) 
for two hours. After hybridisation, the membrane was washed three times for 10 minutes in 
TBS-T buffer and incubated with secondary antibody solution (horseradish peroxidase 
conjugated anti-chicken IgY 1:25 000, 2.5% milk powder in TBS-T, Sigma) for  1 hour. 
Washing steps were performed twice for 10 minutes in TBS-T and once in TBS buffer. For 
detecting the chemoluminescent signal, the SuperSignal® West Pico and Femto Maximum 
Sensitivity Substrates kits (Pierce) were used. Exposing times varied between 30 seconds and 
10 minutes depending on the intensity of the signal. 
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4 Results 
4.1 FET3-GFP assay 
Yeast Mrs3/4p had previously been found to be involved in mitochondrial high-affinity iron 
uptake and were proposed to be the main mitochondrial iron transporters. However, other 
systems for iron import into yeast mitochondria are likely to exist, as the mrs3/4∆ phenotype 
only becomes evident on medium containing low iron. Recently, the pyrimidine nucleotide 
transporter Mrs12p had been shown to function as multi-copy suppressor of the mrs3/4∆ 
phenotype (Wiesenberger, unpublished results).  
In order to investigate this surprising result and to find out if there indeed is a connection 
between Mrs12p and mitochondrial iron transport, we wanted, in a first attempt, to look at the 
expression of genes and proteins involved in iron uptake.  
We chose to perform a FET3-GFP assay, as Fet3p, a ferro-O2-oxidoreductase at the yeast cell 
surface, is part of the high-affinity iron uptake system and its transcription is strongly induced 
under conditions of low iron. Its expression is induced by Aft1p and Aft2p, which are 
inhibited by a signal from mitochondrial iron-sulfur clusters (Rutherford, Ojeda et al. 2005). 
Previous experiments have shown that the protein is up-regulated in mrs3/4∆ mutants. To test 
FET3 expression in mrs12∆ and mrs3/4/12∆ cells, we transformed wild-type ρ0 (Van Dyck, 
Jank et al. 1995), mrs3/4∆ ρ0, mrs12∆ and mrs3/4/12∆ cells with a plasmid containing the 
FET3-GFP construct under its endogenous promoter, grew the cells in medium containing 
high iron concentrations to ensure that induction of FET3 would be due to the diminished 
mitochondrial iron uptake and not to the absence of iron in the cell and checked GFP emission 
of equal cell amounts at 510 nm.  
As displayed in Figure 3, FET3 expression in mrs3/4∆ cells was about three times higher 
than in wild-type cells. mrs12∆ cells showed no significant increase in FET3 expression 
compared to the wild-type, indicating that the high-affinity iron uptake system was not turned 
on by Aft1p and the mrs12∆ mitochondria did not sense iron deprivation. mrs3/4/12∆ cells, 
however, displayed the highest induction of FET3, meaning that even less iron was available 
in their mitochondria than in mrs3/4∆ and that Mrs12p contributes to iron availability in 
mitochondria, but this effect is only visible in the mrs3/4/12∆ mutant. 
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Figure 3: FET3-GFP expression is induced to a higher extent in mrs3/4/12∆ cells than in mrs3/4∆ ρ0 cells. 
W303 ρ0 and GW400 ρ0 (mrs3/4∆) transformed with FET3-GFP were grown in SD -Ura medium supplemented 
with ferric ammonium citrate (50 µg/ml) to early logarithmic phase and diluted to an OD of 1. GFP-emission 
was measured at 510 nm. Standard deviations were calculated from four independent experiments. 
4.2 Gene expression profiling of mrs3/4/12∆ 
As the FET3-GFP did not show up-regulation of FET3 in mrs12∆ cells, we decided to 
perform gene expression profiling of mrs12∆ and mrs3/4/12∆ and compare them to W303 ρ0 
cells to see if other genes involved in cellular iron-uptake would be found to be up-regulated. 
As presented in Table 3, several genes belonging to the iron regulon were up-regulated in the 
mrs3/4/12∆ mutant. These genes are involved in iron or siderophore-iron transport (FTR1; 
FIT2, FIT3), in the degradation of heme (HMX1) or act as transcription factor containing an 
Aft1p consensus motif (TIS11) (Shakoury-Elizeh, Tiedeman et al. 2004; Puig, Askeland et al. 
2005).  
Another up-regulated gene was SLA1, its gene product functions as a cytoskeletal protein 
binding protein, which is required for the assembly of the cortical actin cytoskeleton. Its 
induction might be due to increased stress in the triple mutant.  
Down-regulated genes include the oxalacetate carrier (OAC1), cytochrome c1 (CYT1) and a 
subunit of cytochrome c oxidase (COX5a). These genes code for mitochondrial proteins, 
which are likely to be down-regulated in cells with defects in mitochondrial proteins. Another 
down-regulated gene was dihydroorotate dehydrogenase (URA1), its protein product is 
located in the cytoplasma and catalyzes the fourth step in the de novo biosynthesis of 
pyrimidines. The reason for its down-regulation might be that pyrimidines are not transported 
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into mitochondria in cells lacking Mrs12p and therefore Ura1p is not needed to synthesize 
them de novo. 
 
Table 3: Genome wide expression profile of W303 mrs3/4/12∆ cells shows up-regulation of genes involved 
in iron homeostasis. W303 ρ0 (wild-type) and OS1-2d (mrs3/4/12∆) were grown in SD complete medium 
overnight, diluted to an OD600 = 0.3 and grown to an OD600 of 1.5. RNA isolation, cDNA generation, and probe 
cleanup and microarray hybridization were performed as described in materials and methods. Microarrays were 
read using an Axon GenePix 400B laser scanner and analyzed using the GenePix Pro 3.0 software. Experiments 
were repeated three times with independent cultures. 
 
In mrs12∆ cells, FIT2 and FIT3, two genes of the iron regulon, are induced (data are 
presented in Table 4 by permission of Dr. Jochen Stadler). Fit2p and Fit3p are located in the 
cell wall and are involved in the retention of siderophore-iron. Down-regulated genes include 
pyruvate decarboxylase (PDC1/PDC6), cytosolic aldehyd dehydrogenase (ALD6), 
phosphatidate cytidyltransferase (CDS1) and α-isopropylmalate synthase (LEU4). 
Comparing the gene expression profiles of mrs12∆ and mrs3/4/12∆ to wild-type cells, it can 
be seen that in both FIT2 and FIT3 are induced, indicating a role of mrs12∆ in mitochondrial 
iron acquisition. However, when compared to Mrs3/4p, deletion of Mrs12p only has a minor 
effect on the expression of the iron regulon. As can be seen in the mrs3/4/12∆ mutant, several 
other genes involved in iron transport and homeostasis besides FIT2 and FIT3 are induced, 
which is due to the absence of Mrs3/4p, the main mitochondrial iron transporters.  
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Table 4: Genome wide expression profile of W303 mrs12∆ shows up-regulation of genes involved in iron 
homeostasis. W303 ρ0 (wild-type) and OS1-2d (mrs12∆) were grown in SD complete medium overnight, 
diluted to an OD600 = 0.3 and grown to an OD600 of 1.5. RNA isolation, cDNA generation, and probe cleanup 
and microarray hybridization were performed as described in materials and methods. Microarrays were read 
using an Axon GenePix 400B laser scanner and analyzed using the GenePix Pro 3.0 software. Experiments were 
repeated three times with independent cultures. 
4.3 Construction and analysis of mrs12 G245Y S246A  
4.3.1 Construction of mrs12 G245Y S246A by in vitro mutagenesis 
Mrs12p is, like Mrs3p and Mrs4p, a member of the mitochondrial carrier family. Recently, 
the x-ray structure of the bovine mitochondrial carrier protein ADP/ATP translocase had been 
published (Pebay-Peyroula, Dahout-Gonzalez et al. 2003). Subsequent computational analysis 
and comparative modeling revealed a common binding site for the substrates of the 
mitochondrial carrier proteins (Kunji and Robinson 2006) and the amino acids at the three 
contact points of the binding site have been determined by sequence alignment for all carriers.  
These findings enabled us to create a mutant of MRS12 in the proposed contact point II in 
order to investigate the involvement of this contact point in MRS12 function. We were further 
interested in studying the role pyrimidine transport might play in suppressing the mrs3/4∆ 
phenotype, as iron transport into mrs3/4∆ submitochondrial particles (SMPs) overexpressing 
MRS12 is only seen when pyrimidines are added together with iron (Froschauer, unpublished 
results), whereas previous experiments showed that iron is readily taken up into wild-type 
SMPs, but not in SMPs lacking Mrs3/4p (Froschauer, in press).  
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Figure 4: Construction of the PCR product containing the mrs12 G245Y S246A gene by in vitro 
mutagenesis. The vector pAS14 (MRS12-HA) was used as template. The 1st PCR was run with primers 
containing base changes in the regions of interest (indicated by ×) and a silent EcoRI restriction site (indicated 
by |) (primer1rv or primer2fw) and outside primers (primer1fw or primer2rv). The 2nd PCR was run with outside 
primers and the two products from the 1st PCR to obtain the PCR product. 
 
We decided to mutate the amino acids glycine (G245) and serine (S246) at contact site II of 
Mrs12p into tyrosine and alanine as these two amino acids have very different chemical sizes 
and features and are therefore likely to interfere with normal substrate recognition. Primers 
containing the mutations GGTTCT → TATGCT inside the MRS12 gene sequence were 
constructed together with a silent EcoRI restriction site (GTATAC → GAATTC) to identify 
desired clones. Outside primers were placed in the polylinker regions of the template plasmid 
(pAS14, see appendix for plasmid maps). pAS14 contained the MRS12 gene with a C-
terminal HA-tag, the HA-tag is not functional in the protein (Wiesenberger, personal 
communication), but can be used for protein detection with anti-HA antibody (see Figure 4).  
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The PCR product was cut with BamHI and cloned into the mulit-copy plasmid pAS14 
(MRS12-HA). The vector containing the desired insertion was identified by digestion with 
EcoRI (Figure 5) and called pMH1 (mrs12 G245Y S246A-HA).  
 
 
 
Figure 5:  A second EcoRI restriction site is detected for the vector pMH1 (clone 9), indicating that it 
contains the mrs12 G245Y S246A mutation. Vector pAS14 and clone 9/pMH1 were cut with EcoRI and 
loaded onto a 1% agarose gel for analysis. 
 
Then, pMH1 was cut with NotI and religated to lose the HA-tag, the resulting vector was 
called pMH2 (Figure 6).  
 
 
Figure 6: Construction of vectors pMH1 (mrs12 G245Y S246A-HA) and pMH2 (mrs12 G245Y S246A). 
The PCR product was cut with BamHI and cloned into vector pAS14. The resulting vector was called pMH1. 
pMH1 was cut  with NotI and religated to get rid of the HA-tag. This vector was called pMH2. 
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To obtain a single-copy plasmid with mrs12 G245Y S246A under its endogenous promoter, 
the mrs12 G245Y S246A gene from pMH2 was cloned into the single-copy vector pOLU2 
(YCplac33 backbone), which contained the MRS12 gene under its own promoter. The 
resulting vector was called pMH5 (Figure 7). The vector pMH2 and its low-copy analogue 
pMH5 were used in this work for studying mrs12 G245Y S246A function. 
 
 
Figure 7: Construction of vector pMH5 (mrs12 G245Y S246A, endogenous promoter). Vector pMH2 was 
cut with HindIII and the fragment with mrs12 G245Y S246A was cloned into vector pOLU2, which contained 
the MRS12 gene under its endogenous promoter. Correct orientation of the insert was verified by restriction 
digestion and the resulting vector was called pMH5.  
4.3.2 Complementation studies 
In order to find out if mrs12 G245Y S246A was functional and could complement the mrs12∆ 
phenotype, complementation studies were performed. The mrs12∆ phenotype manifests itself 
by loss of mitochondrial DNA and slow growth on glucose compared to ρ0 wild-type cells, 
therefore cells lacking MR12 form comparatively smaller colonies than isogenic wild-type ρ0 
cells. To avoid mitochondrial DNA loss when comparing phenotypes, the diploid strain 
YAS1(MRS12/mrs12∆) was transformed with plasmids YCplac33, pMH3 
(MRS12.YCplac33) and pMH5 (mrs12 G245Y S246A.YCplac33), transformants were 
sporulated, tetrads dissected and replica-plated onto YPD (to obtain the phenotype), onto SD 
–Ura (to determine which tetrads contain plasmids), onto YPD supplemented with the 
antibiotic geneticin (to select for mrs12∆ colonies) and JJ1A and JJ1C plates (to determine the 
mating type).  Under regular segregation, it is expected that a tetrad deriving from a diploid 
MRS12/mrs12∆ contains two colonies, which carry wild-type MRS12 and show normal 
growth, and two colonies without MRS12, which show reduced growth. As seen in Figure 8, 
this expected 2:2 segregation was observed for cells transformed with the empty plasmid 
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YCplac33. On the other hand, cells transformed with the single-copy plasmid 
MRS12.YCplac33 (pMH3) did not show this segregation pattern, here all colonies had normal 
growth as the MRS12 gene on the plasmid complemented the two tetrads with mrs12∆. By 
comparing transformants with single-copy mrs12 G245Y S246A.YCplac33 (pMH5) with the 
controls, it is evident that these tetrads show a 2:2 segregation.  
 
 
 
Figure 8: mrs12 G245Y S246A does not support complementation of a mrs12∆ mutant.  Diploid YAS1 
(MRS12/mrs12∆) was transformed with YCplac33, with pMH3 (MRS12.YCplac33) and with pMH5 (mrs12 
G245Y S246A.YCplac33). Transformants were sporulated and tetrads were dissected. Tetrads were replica-
plated onto YPD, SD –Ura, YPD + geneticin (200 µg/ml), a lawn of JJ1A (mating type a) and a lawn of JJ1C 
(mating type α). 
 
The reduced growth rate of transformants carrying mrs12 G245Y S246A.YCplac33 could 
also be observed in growth tests, as displayed in Figure 9. From these results, it is obvious 
that the mutated mrs12 G245Y S246A is not able to complement the mrs12∆ phenotype and 
that it is therefore not functional. 
 
 
 
Figure 9: Complementation of the mrs12∆ phenotype is achieved by MRS12, but not by mrs12 G245Y 
S246A. Segregants carrying YCplac33 (W303, mrs12), MRS12.YCplac33 (mrs12∆), mrs12 G245Y 
S246A.YCplac33 (mrs12∆) (all mating type a) were grown in SD –Ura overnight. After cultures were prepared 
and transfered onto YPD and SD –Ura plates complementation of the mrs12∆ phenotype by MRS12.YCplac33 
and by mrs12 G245Y S246A.YCplac33 was compared. 
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4.3.3 Radioactive 3H-TTP uptake into isolated mitochondria  
To further test if pyrimidine transport by MRS12 is impaired in mitochondria carrying mrs12 
G245Y S246A, mitochondria were incubated with radioactive 3H-TTP and uptake was 
measured by scintillation counting. In Figure 10, it can be seen that wild-type ρ0 
mitochondria and mrs12∆ mitochondria overexpressing MRS12 showed about two-fold higher 
uptake than mrs12∆ mitochondria, whereas uptake was not elevated in mrs12∆ mitochondria 
overexpressing mrs12 G245Y S246A compared to the mrs12∆ mitochondria. When 
bathophenanthrolinedisulfonate, an inhibitor of Mrs12p (Marobbio, Di Noia et al. 2006), was 
added to wild-type ρ0 and mrs12∆ mitochondria overexpressing MRS12, the uptake was 
reduced to mrs12∆ level. In the case of mrs12∆ mitochondria and mrs12∆ mitochondria 
overexpressing mrs12 G245Y S246A, addition of bathophenanthrolinedisulfonate did not 
significantly reduce pyrimidine uptake. These observations indicate that pyrimidine uptake is 
impaired in mrs12 G245Y S246A mitochondria and that the mutation in contact point II 
indeed affects the transport function of the protein. 
 
 
 
 
Figure 10: Mitochondria lacking Mrs12p or carrying Mrs12p G245Y S246A do not take up pyrimidines. 
Mitochondria isolated from yeast strain DBY ρ0 or isogenic mutant strains were incubated with radioactive 
labelled 3H-TTP (15 Ci/mmol) or with 3H-TTP and inhibitor bathophenanthroline (20 mM) for 10 minutes, 
filtered through a glass fibre filter and washed with 0.6M sorbitol/20 mM Tris·HCl pH 7.4. The filter was put 
into a scintillation vial, scintillation cocktail was added and scintillation of the sample was counted. 
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4.4 MRS12 and iron transport 
4.4.1 Suppression of the mrs3/4∆ phenotype by overexpression of 
MRS12 or mrs12 G245Y S246A  
The mrs3/4∆ phenotype shows reduced growth on YPD at 37°C, on YPG, on media with low 
iron concentrations and on media supplemented with Cd2+. To test if pyrimidine transport, 
Mrs12p’s assigned function, is essential to suppress the mrs3/4∆ phenotype, mrs3/4∆ cells 
were transformed with plasmid pMH2 carrying the mrs12 G245Y S246A mutation and 
compared with wild-type, mrs3/4∆ mutant and mrs3/4∆ mutant transformed with wild-type 
MRS12. Growth tests clearly showed that mrs3/4∆ cells carrying MRS12 on a multi-copy 
plasmid grew as well on all plates as the wild-type, whereas mrs3/4∆ cells and mrs3/4∆ cells 
transformed with mrs12 G245Y S246A showed reduced or no growth at all (see Figure 11). 
This demonstrates that the mrs12 G245Y S246A mutant cannot suppress the 
mrs3/4∆ phenotype and that functional MRS12 is needed for suppression. 
 
 
 
Figure 11: MRS12 overexpression suppresses the mrs3/4∆ phenotype, whereas mrs12 G245Y S246A 
overexpression does not. DBY474 (wild-type) and GW403 (mrs3/4∆) were transformed with pCM189 and 
mrs3/4∆ cells with MRS12.pCM189 or mrs12 G245Y S246A.pCM189. Transformants were grown in SD –Ura 
medium to an OD600 of 1, diluted and transferred onto YPD, YPD with reduced iron content (supplemented with 
100 µM of the iron chelator bathophenanthrolinedisulfonate (BPS) and 2 µM Fe2+), YPD with cadmium or YPG 
to obtain the mrs3/4∆ phenotype.  
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4.4.2 Immunodetection of MRS12 and mrs12 G245Y S246A 
To control Mrs12p and Mrs12p G245Y S246A expression from multi-copy plasmids, anti-
Rim2-antibody was used to detect the proteins in mitochondrial extracts. Blots and coomassie 
stained gel are shown in Figure 12. No signal was obtained for wild-type and mrs3/4∆ 
mutant, the normal Mrs12p expression level seems to be below detection level of the 
antibody. For cells overexpressing MRS12 or mrs12 G245Y S246A, signals were detected for 
both proteins at about 42 kDa. Hence, it can be concluded that the Mrs12p G245Y S246A 
mutant is not degraded and that lack of mrs3/4∆ suppression is probably due to a non-
functional protein. As shown by the Coomassie gel, equal amounts of protein (40 µg) were 
loaded into each lane. 
In the case of the W303-1A strain, whole cell extracts could be used to obtain a signal by 
western blotting. MRS12 expression from the plasmids seems to be induced to a higher extent 
or Mrs12p is degraded to a lesser extent in this strain than in DBY747, as for the latter 
mitochondrial extracts had to be used to detect Mrs12p signals.  
 
Figure 12: Mrs12p and Mrs12 G245Y S246Ap are detected by anti-Mrs12p-antibody in mitochondrial 
extracts of mrs3/4∆ cells.  Mitochondria were isolated from yeast strains DBY747 (wild-type) and GW403 
(mrs3/4∆) and protein concentrations were determined with the Lowry Method. 40 µg of each protein extract 
were loaded onto a 12% bisacrylamide/acrylamide gel, the gel was run and proteins were transferred onto a 
nitrocellulose membrane. The membrane was incubated with anti-Mrs12-antibody solution and secondary 
antibody solution as described in materials and methods. 
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4.4.3 Iron uptake into submitochondrial particles by MRS12 and mrs12 
G245Y S246A 
To study iron uptake across the inner mitochondrial membrane by Mrs12p in vitro, 
submitochondrial particles (SMPs) were used. Submitochondrial particles are generated from 
mitochondria by exposing these organelles to low osmolarity buffer to generate mitoplasts, 
which lack the outer mitochondrial membrane, and then to ultrasound. This causes 
fragmentation of the mitoplasts and the inner mitochondrial membrane is turned inside out. 
The residual membrane still contains active mitochondrial membrane proteins and can be 
used to determine ion uptake by loading the SMPs with specific fluorescent dyes. These dyes 
act as ion chelators and change their fluorescent emission when they bind ions. For iron 
measurements, the dye PhenGreen SK was used, which shows quenching of fluorescent 
emission at 520 nm upon iron binding. In the following experiments, SMPs deriving from 
wild-type cells, mrs3/4∆ cells, mrs3/4∆ cells overexpressing MRS12 and mrs3/4∆ cells 
overexpressing mrs12 G245Y S246A were studied. 
After addition of Fe2+ to wild-type SMPs quenching was clearly observed, indicating that the 
dye binds the metal inside the SMPs, as wild-type SMPs are able to transport iron across the 
membrane. However, when the main iron transporters Mrs3/4p are absent, no change in 
fluorescent emission was detected, showing that mrs3/4∆ SMPs do not take up iron. In 
mrs3/4∆ SMPs containing high-copy numbers of Mrs12p, iron uptake was observed, but only 
upon prior addition of CTP or TTP, no uptake was seen without CTP/TTP. As shown in 
Figure 13, the amount of iron uptake is dependent on the concentration of the pyrimidine 
nucleotides, higher uptake is detected for increasing concentrations of the nucleotides.  
In mrs3/4∆ SMPs carrying high-copy numbers of the Mrs12p G245Y S246A mutant, iron 
uptake was significantly decreased upon addition of TTP and CTP when compared to 
mrs3/4∆ SMPs with high-copy numbers of Mrs12p (Figure 14). This shows that iron does not 
enter SMPs via Mrs12p without pyrimidine co-transport. 
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Figure 13: Addition of pyrimidine nucleotides stimulates iron uptake into mrs3/4∆ submitochondrial 
particles (SMPs) carrying high-copy numbers of Mrs12p. Mitochondria were isolated from GW403 mrs3/4∆ 
strain overexpressing MRS12, SMPs were prepared and loaded and the fluorescence was measured as described 
in materials and methods.  
 
 
 
Figure 14: Upon addition of pyrimidine nucleotides mrs3/4∆ SMPs carrying high-copy numbers of 
Mrs12p G245Y S256A show decreased iron uptake. Mitochondria were isolated from GW403 mrs3/4∆ strain 
overexpressing MRS12 or mrs12 G245Y S246A, SMPs were prepared and loaded and the fluorescence was 
measured as described in materials and methods. 
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Taken together, these in vitro data show that iron is transported into SMPs by Mrs12p, but 
transport only takes place when pyrimidines are present and when Mrs12p is able to carry out 
pyrimidine transport. 
4.5 MRS12 and Mg2+-transport 
4.5.1 Suppression of the mrs2∆ phenotype by overexpression of MRS12 
or mrs12 G245Y S246A 
So far, we could show that iron was transported along with pyrimidines by Mrs12p. In a next 
step, we assumed that other divalent ions could be taken up together with pyrimidines as well. 
To study this expectation, we chose a strain lacking the MRS2 gene. This gene has been 
identified in a screen for multicopy suppressors of a mitochondrial RNA splicing defect and is 
a mitochondrial inner membrane protein which shares high sequence similarity with the 
bacterial Mg2+ transporter CorA (Bui, Gregan et al. 1999). It functions as the main 
mitochondrial Mg2+ transporter (Kolisek, Zsurka et al. 2003). The mrs2∆ phenotype shows 
reduced growth on media lacking fermentable carbon-sources, but can be suppressed by 
overexpression of several proteins of the inner mitochondrial membrane, including the 
members of the mitochondrial carrier family MRS3 and MRS4.  
Here, it could be observed in growth tests using the DBY747 strain that overexpression of 
MRS12 suppressed the mrs2∆ phenotype on YPG. Consistent with the findings above, no 
suppression was seen for the mrs12 G245Y S246A mutant. For the W303 strain only a slight 
phenotype was seen on YPG and overexpression of mrs12 G245Y S246A resulted in a 
stronger suppression of mrs2∆ than observed in the DBY747 strain (Figure 15). As 
demonstrated for the mrs3/4∆ phenotype, overexpression of MRS12 could also compensate 
for the absence of Mrs2p, the mitochondrial Mg2+ transporter, showing that Mrs12p is also 
able to transport other divalent metals than iron into mitochondria. 
4.5.2 Immunodetection of MRS12 and mrs12 G245Y S246A 
Mrs12p and Mrs12p G245Y S246A were both detected in mitochondrial extracts of cells 
overexpressing MRS12 or mrs12 G245Y S246A by anti-Rim2 antibody. No signals were 
obtained for wild-type or mrs2∆ cells, which do not overexpress MRS12. The detected 
proteins had a size of about 42 kDa, the mutant Mrs12p G245Y S246A was stably expressed 
and not degraded (Figure 16). Therefore, lack of mrs2∆ suppression is due to a non-
functional protein. As shown by the Coomassie gel, equal amounts of protein (40 µg) were 
loaded into each lane. 
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Figure 15: MRS12 overexpression suppresses the mrs2∆ phenotype, whereas mrs12 G245Y S246A does 
not. DBY747 and W303 (wild-type) and isogenic mrs2∆ cells were transformed with pCM189 and mrs2∆ cells 
with MRS12.pCM189, mrs12 G245Y S246A.pCM189 or MRS12.YEp351. Transformed cells were grown in SD 
-Ura to an OD600 of 1 and plated onto YPG or YPdG to obtain the mrs2∆ phenotype. 
 
 
 
Figure 16: Mrs12p and Mrs12p G245Y S246Ap are both detected by anti-Mrs12p-antibody in 
mitochondrial extracts of mrs2∆ cells. Mitochondria were isolated from yeast strains and protein 
concentrations were determined with the Lowry Method. 40 µg of each protein extract were loaded onto a 12% 
bisacrylamide/acrylamide gel, the gel was run and the proteins were transferred onto a nitrocellulose membrane. 
The membrane was incubated in anti-Mrs12-antibody solution and secondary antibody solution as described in 
materials and methods. 
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4.5.3 Mg2+-uptake into isolated mitochondria 
For in organello Mg2+-uptake studies, mitochondria were isolated and incubated with the 
fluorescent dye mag-fura 2. Mag-fura 2 is a membrane permeant acetomethoxyl ester, which 
becomes membrane-impermeant and Mg2+-sensitive upon hydrolysation by mitochondrial 
non-specific esterases. When Mg2+ is bound by the dye, the fluorescent intensities at 340 and 
380 nm change and, according to the following formula (Grynkiewicz, Poenie et al. 1985), the 
340/380 wavelength ratio can be used to calculate [Mg2+]i values: 
 
 
 
R is the ratio of the fluorescence at 340 nm and the fluorescence at 380 nm, Rmin and Rmax are 
the 340 nm/380 nm ratios at 0 and 30 mM Mg2+, KD is the effective dissociation constant of 
the mag-fura 2/Mg2+ complex in breaking buffer (which was determined as 1.52 mM), and F0 
and FS are the 380 nm excitation efficiencies in 0 mM Mg2+ and at saturating Mg2+ (30 mM).  
Upon addition of 1 mM, 5 mM and 10 mM Mg2+ to wild-type mitochondria, an increase in the 
fluorescence at 340 nm and a decrease in the fluorescence at 380 nm were observed, 
reflecting an increase in internal Mg2+. Only minor increase in [Mg2+]i was detected in mrs2∆ 
mitochondria due to the absence of the main mitochondrial Mg2+ transporter Mrs2p. In mrs2∆ 
mitochondria with high-copy numbers of Mrs12p [Mg2+]i increased compared to mrs2∆, but 
did not equal wild-type level. mrs2∆ mitochondria containing Mrs12p G245Y S246A 
displayed Mg2+-uptake in a concentration range between mrs2∆ and mrs2∆ overexpressing 
MRS12 mitochondria (see Figure 17 and Figure 18).  
In a further experiment, we also tried to add pyrimidine nucleotides together with Mg2+ to 
mrs2∆ MRS12 mitochondria to check whether this would stimulate uptake, but as the 
pyrimidines complexed a certain amount of Mg2+ and therefore were competing with mag-
fura 2, exact determination of [Mg2+]i via Rmax and Rmin ratios was not possible. 
However, these findings show that Mrs12p is able to promote Mg2+ uptake and that 
pyrimidine nucleotide transport plays a role in the protein’s ability to suppress the mrs2∆ 
mutation.  
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Figure 17: Mg2+-uptake into mitochondria by Mrs12p and Mrs12p G245Y S246A. Mitochondria were 
isolated from DBY747 (wild-type) and DBY7474 mrs2∆ and loaded with mag-fura2. Samples were measured 
with a spectroflourometer at excitation wavelengths 340 and 380 nm and emission wavelength 509 nm. External 
[Mg2+] was increased to final concentrations of 1, 5 and 10 mM as described in materials and methods.  
 
 
 
 
Figure 18: Quantification of Mg2+-uptake into mitochondria by Mrs12p and Mrs12p G245Y S246A.  
Preparation of samples was carried out as described in Figure 16 and [Mg2+]int values were calculated as 
described in materials and methods. 
 
 42
5 Discussion 
Iron uptake into mitochondria is proposed to be accomplished by the two mitochondrial 
carrier proteins Mrs3/4p. However, it has been suggested that these two proteins do not 
represent the sole system for iron uptake, as the mrs3/4∆ phenotype is only observed under 
iron limiting conditions (Muhlenhoff, Stadler et al. 2003). If iron supply in the cytoplasm is 
sufficient, iron seems to enter the mitochondrion by another route. When searching for a 
possible candidate for iron transport under normal iron concentrations, the MRS12 gene, 
which codes for the mitochondrial pyrimidine nucleotide transporter (Marobbio, Di Noia et al. 
2006), was surprisingly found to act as multi-copy suppressor of the mrs3/4∆ phenotype. To 
our knowledge, no connection between pyrimidine transport and iron uptake into 
mitochondria has been observed to date. 
In this work, an attempt to characterize Mrs12p function in relation to mitochondrial iron 
metabolism and general metal uptake was performed, which support Mrs12p’s role in divalent 
metal transport. 
In a first experiment, we wanted to investigate whether there is a connection between MRS12 
expression and cellular iron homeostasis. In order to study this, we performed a FET3-GFP 
assay. FET3 is a ferro-oxidoreductase at the yeast cell surface, which imports iron when it is 
present in low concentrations (Askwith, Eide et al. 1994). Upon mitochondrial iron depletion, 
FET3 expression is induced by the iron sensing transcription regulator Aft1p and it is also 
induced in mrs3/4∆ cells. In the assay, the triple mutant showed higher expression of the 
ferro-oxidoreductase than the mrs3/4∆ mutant did, which implies that mrs3/4/12∆ cells suffer 
from higher iron deprivation than mrs3/4∆ cells. For mrs12∆ cells, no significant up-
regulation of FET3 was detected. Given the fact that Mrs3/4p are still present in these cells, 
they probably contain enough iron in their mitochondria and so there is no considerable 
shortage of the metal to induce FET3-expression, especially when the cells are grown in iron-
rich media. In this assay, a link between MRS12 and FET3 expression (and therefore cellular 
iron homeostasis) can only be indirectly observed by comparing mrs3/4∆ and mrs3/4/12∆ 
cells. Therefore, we performed genome wide expression profiling of mrs12∆ and mrs3/4/12∆ 
cells to look for other genes involved in iron transport, which might be up-regulated in the 
mutants. 
Genome wide expression profiling of mrs12∆ cells revealed that the two siderophore-iron 
transporters FIT2 and FIT3, which belong to the iron regulon and are under the control of 
Aft1p, were induced (Wiesenberger, unpublished results). This result represents a link 
between MRS12 and cellular iron homeostasis. mrs12∆ cells seem to need elevated 
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concentrations of iron in their cytoplasm compared to wild-type cells to provide the 
mitochondria with normal iron dosages. Why are FIT2/3, but no other genes of the iron 
regulon induced in mrs12∆ cells? An explanation could be that it is not necessary for the cell 
to also induce expression of other iron-related proteins because, in the presence of the high-
affinity iron transporters Mrs3/4p, higher cytosolic iron concentrations automatically lead to 
higher mitochondrial iron content and the additional amount of iron taken up by FIT2/3 into 
the cytoplasm is sufficient to compensate for loss of iron transported into mitochondria by 
Mrs12p.  
Genome wide expression profiling of mrs3/4/12∆ cells showed up-regulation of several genes 
belonging to the iron regulon. This finding was to be expected, as mrs3/4∆ cells already show 
induction of the iron regulon (Muhlenhoff, Stadler et al. 2003). Upon mitochondrial iron 
deprivation due to the absence of Mrs3/4p, mitochondrial iron-sulfur clusters cause activation 
of the iron-sensing transcription factor Aft1p, which in turn induces genes essential for iron 
uptake and iron transport into the cell to compensate for the diminished mitochondrial iron 
content (Rutherford, Ojeda et al. 2005). In the mrs3/4/12∆ mutant, induction of several genes 
of the iron regulon was observed, providing evidence for severe mitochondrial iron 
deprivation.  
According to the findings of the microarray and the FET3-Assay, Mrs12p can be linked to 
mitochondrial iron uptake and could be involved in low-affinity iron transport. It should be 
considered that, if Mrs3p, Mrs4p and Mrs12p were the only transporters delivering iron into 
mitochondria, absence of all three proteins would be lethal for the cell, as iron is needed for 
carrying out Fe-S biogenesis, which is an essential mitochondrial process (Lill, Diekert et al. 
1999). However, the mrs3/4/12∆ mutant is still viable, which would mean that iron uptake 
into mitochondria is, although reduced to a great extent, not totally abolished and that other 
low-affinity iron transporters are probably present.  
In order to study the connection between pyrimidine transport and suppression of the mrs3/4∆ 
phenotype a mutant in contact point II, a proposed substrate binding site of mitochondrial 
carrier proteins (Robinson and Kunji 2006), was created. The amino acids glycine 245 and 
serine 246 were changed into tyrosine and alanine by in vitro mutagenesis. The mutated 
protein was stably expressed, but did not show complementation of the mrs12∆ mutation and 
was not able to transport pyrimidine nucleotides into mitochondria, demonstrating that 
mutations at this site affect the function, but not the stability of the protein. In mitochondrial 
carrier proteins, contact point II is essential for distinguishing between different substrates 
forming a hydrophobic pocket for substrate binding (Robinson and Kunji 2006). We assume 
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that by changing glycine and serine into tyrosine and alanine this hydrophobic pocket is 
destroyed and substrate binding is not properly achieved. Furthermore, suppression of the 
mrs3/4∆ phenotype by mutated mrs12 G2245Y S246A is not observed in the mutant 
anymore. Also, iron transport into submitochondrial particles was studied in mrs3/4∆ and 
mrs3/4∆ SMPs overexpressing MRS12, which showed that, upon addition of pyrimidine 
nucleotides, iron is readily taken up into SMPs overexpressing MRS12, but uptake was 
significantly reduced in the mutant. Thus, we suggest that Mrs12p might mediate iron uptake 
into yeast mitochondria via pyrimidine transport. Pyrimidine uptake into mitochondria is 
essential for suppression of the mrs3/4∆ phenotype, and it is probable that iron is co-
transported with pyrimidine nucleotides.  
Assuming this transport mechanism, Mrs12p might transport other divalent metals in a similar 
manner, especially as it had already been shown that overexpression of MRS12 suppresses the 
mrs2∆ phenotype (Van Dyck, Jank et al. 1995). The phenotype is due to the absence of the 
main mitochondrial Mg2+ transporter Mrs2p (Kolisek, Zsurka et al. 2003), indicating that 
Mrs12p might be involved in Mg2+ uptake by a similar mechanism as in Fe2+ uptake. To test 
this, growth tests of mrs2∆ cells overexpressing MRS12 or the mutant were performed, 
showing that overexpression of MRS12 suppresses the mrs2∆ phenotype, whereas 
overexpression of the mutant does not. Mg2+-Uptake studies into isolated mitochondria using 
the Mg2+ chelator mag-fura 2 resulted in another observation confirming Mrs12p’s 
involvement in mitochondrial Mg2+-acquisition. Here, Mg2+-uptake was increased in mrs2∆ 
mitochondria when MRS12 was overexpressed, but not when the mutant was overexpressed. 
However, upon addition of pyrimidines and Mg2+ to mitochondria, pyrimidines bind Mg2+, 
which unfortunately interferes with the experimental set-up. Therefore, the influence of 
pyrimidine transport on Mg2+ uptake by Mrs12p could not be properly studied, but it presents, 
together with the finding that the mutant mediates much lower Mg2+ uptake than wild-type 
Mrs12p, an indication that pyrimidines have to be transported by Mrs12p in order for divalent 
metals to be taken up by mitochondria. Thus, our findings indicate that Mrs12p is likely to 
have a function as low-affinity divalent metal transporter by coupling pyrimidine uptake to 
metal transport. 
 
How and why might iron be transported by pyrimidine nucleotides via Mrs12p in the 
mitochondrion? A possibility is that iron is complexed to the phosphate moieties of 
pyrimidine nucleotides in a similar way as Mg2+ is proposed to interact with ATP in the Mg2+-
ATP/Pi carrier Sal1p. As anion transport into mitochondria is opposed by the electrochemical 
 45
gradient, coupling their transport to cations provides a way of driving them into the 
mitochondrion against the electrochemical gradient, which might be the case for Sal1p. In 
Sal1p, the phosphate-coordinated magnesium cation interacts with the amino acid glutamate 
E318 at contact point I, which contains the amino acids lysine K314, glutamate E318 and 
lysine K322. A water molecule may be involved in the coordination of the Mg2+ ion. In 
Mrs12p, contact point I includes the amino acids glycine G145, alanine A149 and asparagine 
N153, alanine A149 would correspond to glutamate E318 in Sal1p (Robinson and Kunji 
2006). Glutamate is a negatively charged amino acid, which can coordinate Mg2+, whereas 
alanine is a non-polar amino acid and does not coordinate Mg2+. Also, Mrs12p’s affinity 
towards iron is higher than towards magnesium, as iron uptake into SMPs is not inhibited 
upon addition of aequimolar concentrations of Mg2+ (Froschauer, unpublished results). In 
vivo, Mg2+ concentrations exceed Fe2+ concentrations by a factor of about 500, and it is 
unlikely that Fe2+ would be transported into the mitochondrion if divalent metal transport by 
Mrs12p was completely unspecific. However, different affinities of Mrs12p towards Fe2+ and 
Mg2+ would provide an explanation why Fe2+ is transported. The question of how iron might 
coordinate to amino acids and substrate, however, is not clear. If there is a role of Mrs12p 
contact point I in coordinating iron, comparative modeling and random mutagenesis studies of 
amino acids residues might provide a clue how binding and transport of iron is established.  
Given that Mrs12p can mediate iron and magnesium uptake, transport of other relevant 
divalent metals like Zn2+, Cu2+ and Mn2+ is likely to occur as well. Zn2+ is needed in 
mitochondria as cofactor for several enzymes (Zim17p, Mdj1p) and in Zn-metalloenzymes, 
which are, i.e., involved in alcohol oxidation or leucine biosynthesis (Adh3p, Adh4p, Leu9p) 
or act as metalloproteases. Copper is required for the assembly of cytochrome c oxidase and 
superoxide dismutase. Mitochondrial Mn2+’s only known function is as a cofactor in Mn-
superoxide dismutase, which is important in the protection against oxidative damage (Pierrel, 
Cobine et al. 2007). So far, no mitochondrial transport proteins have been identified for these 
transition metals. However, studies with SMPs demonstrate that Cu2+ and Zn2+ uptake are 
elevated in SMPs deriving from cells overexpressing MRS12 when compared to wild-type 
SMPs, but not from cells overexpressing the mutant. Interestingly, if the pH inside SMPs is 
lowered, Fe2+ uptake into mrs3/4∆ SMPs carrying Mrs12p decreases (Froschauer, 
unpublished results). According to these data, Mrs12p seems to be able to mediate uptake of 
other transition metals besides iron as well and therefore could function as low-affinity 
divalent metal transporter in mitochondria. As mentioned above, coupling anion transport 
across the inner mitochondrial membrane to cations represents a way of driving them into the 
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mitochondrion against the electrochemical gradient. The transport of pyrimidines and cations 
might depend on the electrochemical gradient, as uptake decreases when the pH inside SMPs 
is lowered.  
Considering that mitochondria possess several transporters belonging to the mitochondrial 
carrier family, which transport a variety of substrates from nucleotides to amino acids across 
the inner mitochondrial membrane, the pyrimidine transporter Mrs12p might not be the only 
transporter involved in metal uptake. Studies have shown that the mitochondrial GTP/GDP 
carrier protein Ggc1p plays a role in mitochondrial iron metabolism, as absence of Ggc1p 
leads to high cellular iron uptake and iron accumulation in the mitochondrial matrix 
(Lesuisse, Lyver et al. 2004). Normal iron regulation is restored when a human nucleoside 
diphosphate kinase, which converts ATP into GTP, is targeted to the matrix of ggc1∆ mutants 
(Gordon, Lyver et al. 2006). However, there is no link to mitochondrial iron uptake in this 
study. According to the authors, mitochondrial iron metabolism is affected by GTP/GDP 
levels in the mitochondrial matrix and absence of GTP leads to accumulation of iron. Also, a 
recent study shows that GTP is required for iron-sulfur cluster biogenesis in mitochondria 
(Amutha, Gordon et al. 2008), which might be an explanation for iron accumulation in the 
mutant. Given that our findings point to a role of the pyrimidine transporter Mrs12p in iron 
uptake, it can still be speculated that the purine Gcg1p transporter might mediate iron uptake 
via purine transport, but suppression experiments in mrs3/4∆ strains overexpressing GCG1 
have to be performed in order to study this in more detail.  
It should also be mentioned that in an attempt to find further suppressors of the mrs3/4∆ iron 
phenotype, a mrs3/4∆ mutant was transformed with a library obtained from a mrs3/4/12∆ 
strain, but only very weak suppressors (i.e. ORC1, which codes for the mitochondrial 
ornithine transporter (Fiermonte, Dolce et al. 2003)) compared to MRS12 were found 
(Wiesenberger, Binder, personal communication). This suggests that only MRS12 can 
suppress the iron phenotype of mrs3/4∆ mutants under the conditions of the screen and that 
there might be no other transporter involved in iron transport. 
What is the physiological relevance of our findings? A speculative scenario is that yeast 
mitochondria comprise a general unspecific cation uptake system coupled to anion transport, 
which has been observed for Mrs12p or Sal1p and might also be of relevance for other 
mitochondrial carriers, and a specific cation uptake system, which contains high-affinity iron 
transporters Mrs3/4p, the Mg2+ channel Mrs2p and other not yet identified proteins. 
Selectivity is not required in the case of the general uptake system, as it only supplies the 
mitochondrion with basal metal concentrations. When a specific ion is needed inside the 
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matrix, high-affinity transporters mediate selective cation uptake and ensure adequate metal 
ion supply. This system would provide yeast mitochondria the ability to adapt to metal ion 
availability and to regulate uptake and distribution of metal ions accordingly. 
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6 Appendix 
6.1 Plasmid Maps 
pMH1 
Plasmid: pMH1 Date:  03/03/08 
Backbone: pCM189 Size:    9,600 kb 
Markers: Ampr, URA3 
Host Strain:  DH10B 
References:  MH book 779, p005 
Stock: E. coli box (freezer cultures) 
Construction: pAS14 (MRS12-HA in pCM189) was cleaved with BamHI, 
treated with Cip and ligated to a 1.2 kb BamHI fragment 
containing the mrs12 G245Y, S246A gene. 
 
Comment:  No backup clone (clone contains additional mutation) 
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pMH2 
 
Plasmid: pMH2 Date:  05/03/08 
Backbone: pCM189 Size:    9,489 kb 
Markers: Ampr, URA3 
Host Strain:  DH10B 
References:  MH book 779, p007 
Stock: E. coli box (freezer cultures) 
Construction: pMH1 (mrs12 G245Y, S246A-HA in pCM189) was cleaved with 
NotI to cut out HA-tag and religated  
 
Comment:  1 backup clone 
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pMH3 
 
Plasmid: pMH3 Date:  10/03/08 
Backbone: YCpLac33 Size:    7,733 kb 
Markers: Ampr, URA3 
Host Strain:  DH10B 
References:  MH book 779, p010 
Stock: E. coli box (freezer cultures) 
Construction: pOLU2 (MRS12 in YCplac33) was cleaved with HindIII, treated 
with Cip and the 6.7 kb fragment was ligated to the 1.2 kb 
HindIII fragment from pAS12 (MRS12 in pCM189). 
 
Comment:  1 backup clone  
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pMH4 
 
Plasmid: pMH4 Date:  10/03/08 
Backbone: YCpLac33 Size:    7,844 kb 
Markers: Ampr, URA3 
Host Strain:  DH10B 
References:  MH book 779, p010 
Stock: E. coli box (freezer cultures) 
Construction: pOLU2 (MRS12 in YCplac33) was cleaved with HindIII, treated 
with Cip and the 6.7 kb fragment was ligated to the 1.2 kb 
HindIII fragment from pMH1 (mrs12 G245Y, S246A -HA in 
pCM189). 
 
Comment:  1 backup clone  
 
 
 
 
 
 52
pMH5 
 
Plasmid: pMH5 Date:  10/03/08 
Backbone: YCpLac33 Size:    7,733 kb 
Markers: Ampr, URA3 
Host Strain:  DH10B 
References:  MH book 779, p010 
Stock: E. coli box (freezer cultures) 
Construction: pOLU2 (MRS12 in YCplac33) was cleaved with HindIII, treated 
with Cip and the 6.7 kb fragment was ligated to the 1.2 kb 
HindIII fragment from pMH2 (mrs12 G245Y, S246A in pCM189). 
 
Comment:  1 backup clone  
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pAS12 
 
Plasmid: pAS12  
Backbone: pCM189 Size:    9,489 kb 
Markers: Ampr, URA3 
Host Strain:  DH10B 
References:  MH book 778, 779 
Stock: E. coli box (freezer cultures) 
Construction:  MRS12 was cleaved with BamHI/PstI from pAS17 and the 1,2 kb 
fragment containing the MRS12 ORF was ligated into pCM189 
cut with the same enzymes. The resulting plasmid was called 
pAS 12 
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pAS14 
 
Plasmid: pAS14  
Backbone: pCM189 Size:    9,600 kb 
Markers: Ampr, URA3 
Host Strain:  DH10B 
References:  MH book 778, 779 
Stock: E. coli box (freezer cultures) 
Construction: The HA-tag was cut out with NotI from YEp351-HA and inserted 
in frame into NotI cleaved pAS12 resulting in an in frame fusion 
of the HA tag to the MRS12 ORF (by Axel Struß). 
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pOLU2 
 
Plasmid: pOLU2  
Backbone: YCpLac33 Size:    8,834 kb 
Markers: Ampr, URA3 
Host Strain:  DH10B 
References:  MH book 779 
Stock: E. coli box (freezer cultures) 
Construction: A 3.2kb XbaI fragment from MRS12.Yep351 (Gerlinde) was 
cloned into XbaI site of YCplac33.   
Comment: “Anti sense” Orientation with respect to the polylinker (HindIII-
EcoRI)     
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